BDNF and Alzheimer disease: They measured CpG site methylation at four locations within two promoter regions of the BDNF gene and found that elevated methylation of a site within the promoter IV area significantly (HR = 3.51, p = 0.013) associated with the conversion of MCI to AD [41].